Caris Life Sciences Inc (CAI) · Earnings Release

Livzon Pharmaceutical Group Inc (1513) · Other

Ex-dividend date for the final dividend of RMB 1.43 per share for the fiscal year 2025 on 2026-06-16, scheduled.

6/16/2026, 12:00:00 AM

Biocytogen Pharmaceuticals (Beijing) Co Ltd (2315) · Other

Annual General Meeting to be held on 2026-05-21 to review reports and approve plans; routine meetings typically have a 1-5% price impact, scheduled

5/21/2026, 12:00:00 AM

Shanghai Fosun Pharmaceutical (Group) Co Ltd (2196) · Other

An earnings briefing for the 2025 fiscal year and Q1 2026 results is scheduled for May 14, 2026. This routine communication event is estimated to have a price impact of at least 1% scheduled.

5/14/2026, 12:00:00 AM

Guardant Health Inc (GH) · Earnings Release

Guardant Health is scheduled to release its Q1 2026 financial results after market close on May 7, 2026. Analysts forecast EPS of ($0.47) and revenue of $279.17 million. High importance estimated due to potential for significant volatility following earnings results, scheduled.

5/7/2026, 12:00:00 AM

Natera Inc (NTRA) · Earnings Release

Natera is scheduled to release its first quarter 2026 financial results after the market closes on May 7, 2026, with analysts forecasting revenue of approximately $617.5 million and an EPS of -$0.55; high importance is expected due to typical earnings volatility, scheduled.

5/7/2026, 12:00:00 AM

10x Genomics Inc (TXG) · Earnings Release

10x Genomics is scheduled to report its financial results for the first quarter of 2026 after market close on May 7, 2026, followed by a conference call; analysts forecast earnings of ($0.25) per share. High importance is estimated as earnings releases often trigger >10% price movement forecasted scheduled

5/7/2026, 12:00:00 AM